Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Lung Cancer

  Free Subscription

Articles published in J Clin Invest

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    January 2021
  1. GUO J, Liu Y, Lv J, Zou B, et al
    BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors.
    J Clin Invest. 2021;131.
    PubMed     Abstract available

    October 2020
  2. HUANG F, Huffman K, Wang Z, Wang X, et al
    Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small cell lung cancer.
    J Clin Invest. 2020 Oct 20. pii: 139929. doi: 10.1172/JCI139929.
    PubMed     Abstract available

    NK cells in the tumor microenvironment and thioredoxin activity.
    J Clin Invest. 2020;130:5115-5117.
    PubMed     Abstract available

  4. YANG Y, Neo SY, Chen Z, Cui W, et al
    Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.
    J Clin Invest. 2020;130:5508-5522.
    PubMed     Abstract available

    August 2020
  5. COCHRANE CR, Vaghjiani V, Szczepny A, Jayasekara WSN, et al
    Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
    J Clin Invest. 2020;130:4006-4018.
    PubMed     Abstract available

    July 2020
  6. YAN C, Richmond A
    Th9 and Th17 cells: the controversial twins in cancer immunity.
    J Clin Invest. 2020;130:3409-3411.
    PubMed     Abstract available

    June 2020
  7. LIU J, Zhang C, Wu H, Sun XX, et al
    Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    J Clin Invest. 2020;130:3253-3269.
    PubMed     Abstract available

    April 2020
  8. CONEJO-GARCIA JR, Rodriguez PC
    c-Maf: a bad influence in the education of macrophages.
    J Clin Invest. 2020;130:1629-1631.
    PubMed     Abstract available

  9. HU K, Li K, Lv J, Feng J, et al
    Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
    J Clin Invest. 2020;130:1752-1766.
    PubMed     Abstract available

  10. VALENCIA K, Erice O, Kostyrko K, Hausmann S, et al
    The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
    J Clin Invest. 2020;130:1879-1895.
    PubMed     Abstract available

    March 2020
  11. SALAZAR Y, Zheng X, Brunn D, Raifer H, et al
    Microenvironmental Th9- and Th17- lymphocytes induce metastatic spreading in lung cancer.
    J Clin Invest. 2020 Mar 31. pii: 124037. doi: 10.1172/JCI124037.
    PubMed     Abstract available

    February 2020
  12. LIN M, Luo H, Liang S, Chen J, et al
    Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.
    J Clin Invest. 2020 Feb 6. pii: 132712. doi: 10.1172/JCI132712.
    PubMed     Abstract available

  13. BOUSQUET MUR E, Bernardo S, Papon L, Mancini M, et al
    Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.
    J Clin Invest. 2020;130:612-624.
    PubMed     Abstract available

    January 2020
  14. LIU M, Tong Z, Ding C, Luo F, et al
    Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
    J Clin Invest. 2020 Jan 16. pii: 131335. doi: 10.1172/JCI131335.
    PubMed     Abstract available

  15. SIEBEN CJ, Jeganathan KB, Nelson GG, Sturmlechner I, et al
    BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome.
    J Clin Invest. 2020;130:171-188.
    PubMed     Abstract available

    November 2019
  16. SUZUKI M, Cao K, Kato S, Komizu Y, et al
    Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
    J Clin Invest. 2019;129:5050.

    July 2019
  17. SUZUKI M, Cao K, Kato S, Komizu Y, et al
    Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
    J Clin Invest. 2019;130.

    April 2019
  18. KELLISH P, Shabashvili D, Rahman MM, Nawab A, et al
    Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
    J Clin Invest. 2019;130.
    PubMed     Abstract available

    January 2019
  19. ZHAO G, Gong L, Su D, Jin Y, et al
    Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin beta1.
    J Clin Invest. 2019 Jan 28. pii: 122779. doi: 10.1172/JCI122779.
    PubMed     Abstract available

  20. CHEN M, Zhang J, Berger AH, Diolombi MS, et al
    Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.
    J Clin Invest. 2019;129:215-222.
    PubMed     Abstract available

    December 2018
  21. CHABANON RM, Muirhead G, Krastev DB, Adam J, et al
    PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
    J Clin Invest. 2018 Dec 27. pii: 123319. doi: 10.1172/JCI123319.
    PubMed     Abstract available

    April 2018
  22. GONG K, Guo G, E Gerber D, Gao B, et al
    TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.
    J Clin Invest. 2018 Apr 3. pii: 96148. doi: 10.1172/JCI96148.
    PubMed     Abstract available

    February 2018
  23. TOUAT M, Sourisseau T, Dorvault N, Chabanon RM, et al
    DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
    J Clin Invest. 2018 Feb 15. pii: 90277. doi: 10.1172/JCI90277.
    PubMed     Abstract available

    January 2018
  24. CHOCKLEY PJ, Chen J, Chen G, Beer DG, et al
    Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    J Clin Invest. 2018 Jan 11. pii: 97611. doi: 10.1172/JCI97611.
    PubMed     Abstract available

    October 2017
  25. WEI Y, Kim TJ, Peng DH, Duan D, et al
    Fibroblast-specific inhibition of TGF-beta1 signaling attenuates lung and tumor fibrosis.
    J Clin Invest. 2017;127:3675-3688.
    PubMed     Abstract available

    August 2017
  26. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    PubMed     Abstract available

  27. WANG YT, Chen J, Chang CW, Jen J, et al
    Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.
    J Clin Invest. 2017;127:2982-2997.
    PubMed     Abstract available

  28. AYERS M, Lunceford J, Nebozhyn M, Murphy E, et al
    IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade.
    J Clin Invest. 2017;127:2930-2940.
    PubMed     Abstract available

    June 2017
    A SMAP in the face for cancer.
    J Clin Invest. 2017;127:2048-2050.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.